These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8152221)
21. Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model. Millar HJ; Nemeth JA; McCabe FL; Pikounis B; Wickstrom E Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2180-7. PubMed ID: 18708412 [TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice]. He DM; Zhang H Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747 [TBL] [Abstract][Full Text] [Related]
23. In vivo effect of pachymatismin, a new marine glycoprotein, on a human non-small-cell lung carcinoma. Zidane M; Moré MT; Pondaven P; Jaquot C; Riou D; Roussakis C In Vivo; 1997; 11(2):185-8. PubMed ID: 9179614 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076 [TBL] [Abstract][Full Text] [Related]
25. Cellular predictive factors for the drug response of lung cancer. Volm M; Rittgen W Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647 [TBL] [Abstract][Full Text] [Related]
26. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug. Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972 [TBL] [Abstract][Full Text] [Related]
28. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Harper E; Dang W; Lapidus RG; Garver RI Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366 [TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effects of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on non-small lung cell cancer: an experimental with rats]. Tang YM; Yang SF; Zhu B; Cui JS Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2021-5. PubMed ID: 16313792 [TBL] [Abstract][Full Text] [Related]
30. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823 [TBL] [Abstract][Full Text] [Related]
31. Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer. Hu Y; Bebb G; Tan S; Ng R; Yan H; Sartor JR; Mayer LD; Bally MB Clin Cancer Res; 2004 Nov; 10(22):7662-70. PubMed ID: 15569999 [TBL] [Abstract][Full Text] [Related]
32. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533 [TBL] [Abstract][Full Text] [Related]
33. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734 [TBL] [Abstract][Full Text] [Related]
34. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663 [TBL] [Abstract][Full Text] [Related]
36. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317 [TBL] [Abstract][Full Text] [Related]
37. Antegrade versus retrograde isolated lung perfusion: doxorubicin uptake and distribution in a sarcoma model. Krueger T; Kuemmerle A; Andrejevic-Blant S; Yan H; Pan Y; Ballini JP; Klepetko W; Decosterd LA; Stupp R; Ris HB Ann Thorac Surg; 2006 Dec; 82(6):2024-30. PubMed ID: 17126104 [TBL] [Abstract][Full Text] [Related]
38. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Bunn PA; Helfrich BA; Brenner DG; Chan DC; Dykes DJ; Cohen AJ; Miller YE Clin Cancer Res; 1998 Nov; 4(11):2849-58. PubMed ID: 9829752 [TBL] [Abstract][Full Text] [Related]
39. Irradiated nude rat model for orthotopic human lung cancers. Howard RB; Chu H; Zeligman BE; Marcell T; Bunn PA; McLemore TL; Mulvin DW; Cowen ME; Johnston MR Cancer Res; 1991 Jun; 51(12):3274-80. PubMed ID: 2040002 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. Minchin RF; Johnston MR; Aiken MA; Boyd MR J Pharmacol Exp Ther; 1984 Apr; 229(1):193-8. PubMed ID: 6707934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]